The adaptation of lipid nanocapsule formulations for blood administration in animals
Authors:
- J. HureauxJHJ. Hureaux
- F. LagarceFLF. Lagarce
- F. GagnadouxFGF. Gagnadoux
- A. ClavreulACA. Clavreul
- J.-P. BenoitJBJ.-P. Benoit
- T. UrbanTUT. Urban
- 1 September 2009
- journal article
- research article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 379 (2) , 266-269
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Lipid nanocapsules loaded with an organometallic tamoxifen derivative as a novel drug-carrier system for experimental malignant gliomasJournal of Controlled Release, 2008
- Formulation of sustained release nanoparticles loaded with a tripentone, a new anticancer agentInternational Journal of Pharmaceutics, 2006
- A new generation of anticancer, drug-loaded, colloidal vectors reverses multidrug resistance in glioma and reduces tumor progression in ratsMolecular Cancer Therapeutics, 2006
- Enhanced Oral Paclitaxel Bioavailability After Administration of Paclitaxel-Loaded Lipid NanocapsulesPharmaceutical Research, 2006
- Etoposide nanocarriers suppress glioma cell growth by intracellular drug delivery and simultaneous P-glycoprotein inhibitionJournal of Controlled Release, 2006
- Long Circulating Poly(Ethylene Glycol)-Decorated Lipid Nanocapsules Deliver Docetaxel to Solid TumorsPharmaceutical Research, 2006
- Lipid nanocarriers as drug delivery system for ibuprofen in pain treatmentInternational Journal of Pharmaceutics, 2004
- New lipid nanocapsules exhibit sustained release properties for amiodaroneJournal of Controlled Release, 2002
- A Novel Phase Inversion-Based Process for the Preparation of Lipid NanocarriersPharmaceutical Research, 2002
- A good practice guide to the administration of substances and removal of blood, including routes and volumesJournal of Applied Toxicology, 2001